Couples undergoing in vitro fertilization (IVF) are presented with a dizzying number of choices as they navigate the process — from selecting a retrieval method to selecting the sex of their fetus.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A U.S.-based biotech company has unveiled a new in vitro fertilization ...

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These ...

Nucleus Genomics unveiled a $5,999 service Wednesday allowing prospective parents to rank embryos created during in vitro fertilization (IVF) by projected IQ, height, eye color and nearly 900 ...

CHICAGO — A genetic testing company largely lost its bid for dismissal of a putative class action accusing it of falsely marketing its genetic testing to screen in vitro-fertilized embryos for ...

Nucleus Genomics, a genetic testing startup founded by 25-year-old Kian Sadeghi, initially launched in 2021 with the goal of calculating a patient’s risk for specific diseases. But it’s been courting ...

Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King's College London, King's College Hospital, and King's Fertility ...